London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK.
Global Health. 2014 Feb 24;10:11. doi: 10.1186/1744-8603-10-11.
Diabetes has become an increasingly prevalent and severe public health issue in Algeria. This article investigates the prevalence, the cost and the management of this disease. Its first objective is to better understand the burden (both from an epidemiological and economic perspective) and management of diabetes. The second objective is to understand the health policy strategy adopted by Algeria in order to respond to the disease.
We conducted a literature review of prevalence, costs, management and outcomes of diabetes and its complications. This was complemented by data compilations and results of expert consultations.
The epidemiology of diabetes is continually evolving and is becoming more problematic. The national evidence suggests that the prevalence of diabetes in Algeria has increased from 6.8% in 1990 to 12.29% in 2005, but is quite higher among certain groups and areas of the country. This disease affects all population groups, especially 35-70 year olds, who constitute a large segment of the working population. There are very few estimates of the cost of diabetes. These include a 1998 study on the total cost of type 1 diabetes (USD 11.6 million, which, inflated to 2013 value, totals to USD 16.6 million), a study on the cost of complications in 2010 (at 2013 value, ranging from USD 141 for first-year treatment of peripheral vascular disease to USD 30,441 for first-year cost of renal transplantation) and the 2013 IDF estimates of total cost of type 1 and type 2 diabetes (USD 513 million).
As the prevalence of diabetes continues to increase, the financial burden will increasingly weigh heavily on social security resources and the government budget. Future priorities must focus on empowering general practitioners in treating type 2 diabetes, improving screening of diabetes and its complications, tackling the growing obesity epidemic, strengthening health information systems and implementing the national diabetes prevention and control plan.
糖尿病已成为阿尔及利亚日益严重的公共卫生问题。本文研究了该疾病的流行情况、成本和管理。其首要目标是更好地了解糖尿病的负担（从流行病学和经济学角度来看）和管理。第二个目标是了解阿尔及利亚采取的卫生政策战略，以应对该疾病。
我们对糖尿病及其并发症的流行情况、成本、管理和结果进行了文献回顾。这一研究还辅以数据汇编和专家咨询的结果。
糖尿病的流行病学情况在不断演变，且变得更加复杂。国家证据表明，阿尔及利亚的糖尿病患病率从 1990 年的 6.8%上升到 2005 年的 12.29%，但在该国某些群体和地区更高。这种疾病影响所有人群，尤其是 35-70 岁的人群，他们是劳动人口的主要组成部分。糖尿病成本的估计很少。其中包括 1998 年对 1 型糖尿病总成本的研究（1160 万美元，按 2013 年的价值计算，总计 1660 万美元）、2010 年对并发症成本的研究（按 2013 年的价值计算，从外周血管疾病第一年治疗的 141 美元到第一年肾移植的 30441 美元不等）以及 2013 年 IDF 对 1 型和 2 型糖尿病总成本的估计（5.13 亿美元）。
随着糖尿病的流行率继续上升，财政负担将越来越多地压在社会保障资源和政府预算上。未来的优先事项必须集中在授权全科医生治疗 2 型糖尿病、改善糖尿病及其并发症的筛查、解决日益严重的肥胖症流行、加强卫生信息系统和实施国家糖尿病预防和控制计划。
